Also in the oral GLP-1RA ring is pharma giant Pfizer with its candidate danuglipron. In a Phase IIb trial (NCT04707313), the ...

In the first of several readouts expected from a Phase III programme, Lilly said its oral glucagon-like peptide-1 receptor agonist (GLP-1RA ... taking the highest dose of orforglipron achieving ...

Third, not all studies used standardized dosing of GLP-1RA therapy recommended in clinical practice (Table 1) and/or did not ensure that GLP-1RAs were at steady-state concentrations. Finally ...

ZT002 was safe and well tolerated in both biweekly and monthly dosing arms in patients with overweight or obesity with a tolerability profile aligned with the GLP-1RA class The presentation titled ...

Indiana clinical-stage biopharmaceutical company, MBX Biosciences, has announced positive topline data from a Phase I trial of its glucagon-like peptide-1 receptor agonist (GLP-1RA) aimed at ...

ZT002 was safe and well tolerated in both biweekly and monthly dosing arms in patients with overweight or obesity with a tolerability profile aligned with the GLP-1RA class – The open-label extension ...